DAFNA Capital Management »

Tenaya Therapeutics shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $222k 300k 0.74
2025-03-31 $27k 47k 0.57

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Tenaya Therapeutics

Vanguard Capital Management
Millennium Management
Citadel Advisors
Renaissance Technologies
BlackRock
Empery Asset Management
Marshall Wace
GSA Capital Partners
Burkehill Global Management
Geode Capital Management
ADAR1 Capital Management
Raiffeisen Bank International
Euclidean Capital
Vanguard Fiduciary Trust
Mirador Capital Partners

View all funds holding Tenaya Therapeutics